News Biofrontera mulls US IPO to fund skin cancer drug German biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin cancer drug.
News Merck KGaA and Pfizer break into cancer immunotherapy Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer.
News AI on par with dermatologists at diagnosing skin cancer Technology could inspire a smartphone-based skin cancer diagnostic app.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Articles Digital health round-up - skin cancer, vocal biomarkers and ... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
